Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by ggh2257on Oct 17, 2015 9:32am
393 Views
Post# 24201023

Latest Roche CEO interview...

Latest Roche CEO interview...Regarding a potential new deal for an ind of PBI 4050, it seems that the recent "buble" for small biotech are getting out of hand for bigger pharmas. The InterMune deal at 8 $B may not happen again in the short term...
Big pharmas are forced to look at earlier stage products more and more!

See latest CEO interview!

https://www.reuters.com/article/2015/09/15/us-roche-m-a-ceo-idUSKCN0RF2B120150915

GLTA, GGH2257


Bullboard Posts